Pediatric patients often have unique medical needs that differ from adults, and the rarity of certain pediatric conditions can make it difficult for medical device manufacturers to justify the significant investment required for traditional FDA approval. The HDE pathway helps bridge this gap, ensuring that children with rare conditions have access to potentially life-saving devices. This is crucial as the development of pediatric-specific devices is often limited by market constraints and economic factors.
